Healthcare and pharma are under pressure from every direction at once: aging populations, rising chronic disease, drug development costs in the billions, and a workforce that is burning out faster than it can be replaced. The global market for AI in healthcare is projected to grow at over 35% CAGR through the decade (Grand View Research, 2024) - not because the industry chases hype, but because the math on manual workflows no longer adds up.
Where AI delivers the clearest return is rarely the headline use cases. It is in the unglamorous middle of the operational stack: prior authorizations that take days when they should take hours, pharmacovigilance reports that consume specialist time better spent on patients, intake forms that get re-keyed three times across systems, and trial documentation that ties up CROs and sponsors in coordination overhead.
We build for those workflows specifically, under the regulatory frameworks they live in. Every system we deliver is architected to demonstrate lawful processing of patient data, to produce decisions your medical and regulatory teams can review, and to fit inside the IRB, ethics committee, and quality management oversight your organization already operates.